Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Zymride M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Walron Healthcare Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Zymride M 0.5 Tablet PR

Diabetace Duo 0.5mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetace Duo 0.5mg tablets should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with well-controlled blood sugar, as discontinuation without medical consultation can lead to elevated blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are crucial for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is another potential consequence. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals must consult their doctor. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Zymride M 0.5 Tablet PR

No text provided to rephrase.

Uses of Zymride M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Zymride M 0.5 Tablet PR:

Follow your doctor's instructions or the product label for proper administration. Consume Zymride M 0.5 Tablet PR with a meal.

Common Side effects of Zymride M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Zymride M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product information leaflet before taking Zymride M 0.5 Tablet PR. This medication should be administered with food.

How Zymride M 0.5 Tablet PR works:

Zymride M 0.5 PR tablets contain glimepiride and metformin, a dual-action antidiabetic regimen. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zymride M 0.5 Tablet PR and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zymride M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Zymride M 0.5 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Zymride M 0.5 Tablet PR with close medical supervision, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Zymride M 0.5 Tablet PR. Regular monitoring of kidney function is recommended during treatment. Consult your physician for guidance.

LiverLiverCAUTION

Patients with liver impairment should use Zymride M 0.5 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Zymride M 0.5 Tablet PR :

Should you forget to take a Zymride M 0.5 Tablet PR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zymride M 0.5 Tablet PR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Zymride M 0.5 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Zymride M 0.5 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zymride M 0.5 Tablet PR and seek immediate medical attention.
Zymride M 0.5 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Zymride M 0.5 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Zymride M 0.5 Tablet PR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zymride M 0.5 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Zymride M 0.5 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Zymride M 0.5 Tablet PR
26
MRP 30
13% off